For citations:

Alekseev B.Ya., Matveev V.B., Chkhotua A., Markova A.S. Safety of enzalutamide in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: a phase II, multicenter, single-arm, open-label study. Cancer Urology. 2018;14(1):117-125. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-1-117-125